Related Experiment Video
Updated: Jun 13, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review
Giovanni Cerasola1, Emilio Nardi, Alessandro Palermo
1Department of Internal Medicine, Cardiovascular and Renal Diseases, University of Palermo, Palermo, Italy. medint@unipa.it
Insights
Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, affecting over 70% with end-stage renal disease. Early detection of LVH and diastolic dysfunction in CKD is crucial for improving cardiovascular outcomes.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular diseases (CVD) are a leading cause of mortality in chronic kidney disease (CKD) patients.
- Left ventricular (LV) abnormalities, including hypertrophy (LVH) and dysfunction, are highly prevalent in CKD and worsen cardiovascular prognosis.
Purpose of the Study:
- To review the literature on left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).
- To understand the prevalence, determinants, and clinical implications of LVH and diastolic dysfunction in CKD.
Main Methods:
- A literature search was conducted using PubMed for studies on left ventricular hypertrophy (LVH) in chronic kidney disease (CKD).
- The review considered various definitions of LVH used across different studies.
Main Results:
- Prevalence of LVH exceeds 70% in end-stage renal disease (ESRD) patients.
- LVH prevalence increases with declining renal function in earlier stages of CKD.
- Significant heterogeneity exists in reported LVH prevalence due to variations in study populations, GFR estimation methods, and LVH definitions.
Conclusions:
- Major determinants of LVH in CKD include hypertension, fluid/electrolyte imbalances, and anemia.
- Non-hemodynamic factors like RAAS activation, oxidative stress, inflammation, and growth factors also contribute to LVH.
- LV diastolic dysfunction is common, occurs early, and is linked to heart failure and mortality, even without LVH.
- Early identification of LVH and LV dysfunction in CKD patients may improve cardiovascular outcomes.
Introduction:
Cardiovascular diseases are highly prevalent in patients with chronic kidney disease (CKD), and represent the major hazard for mortality in this population. Anomalies of left ventricular (LV) structure and function are very frequent too among CKD patients, and show a negative impact on cardiovascular prognosis.
Methods:
We searched PubMed for manuscripts regarding left ventricular hypertrophy (LVH) in CKD. Definition of LVH was different according to different studies.
Results:
In patients with end-stage renal disease, the prevalence of LVH is higher than 70%. Studies in patients with less advanced CKD have reported increasing prevalence of LVH along with declining renal function. However, there is relatively wide heterogeneity in the prevalence of LVH in different studies, according to the characteristics of the population studied, the method chosen to estimate glomerular filtration rate and the definition of LVH.
Conclusions:
Hypertension, alterations of fluid and electrolyte balance and anemia are identified as the major determinants of LVH in CKD. However, beyond hemodynamic factors, other factors, such as an inappropriate activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation and collagen and muscle cell growth factors may have a relevant role. LV diastolic dysfunction is also very frequent among CKD patients and is associated with risk of heart failure and with mortality; impairment of diastolic function in patients with CKD may occur very early, even in the absence of LVH. Early detection of LVH and LV dysfunction in CKD could yield an improvement in the adverse cardiovascular outcomes of CKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
